Multicenter Early Access Program Results from Turkey: Efficacy and Safety of Daratumumab Among Heavily Pretreated Relapse/Refractory Multiple Myeloma Patients

---

Beksac M., Aydin Y., Goker H., Turgut M., Besisik S. , Cagirgan S., ...More

59th Annual Meeting of the American-Society-of-Hematology (ASH), Georgia, United States Of America, 9 - 12 December 2017, vol.130

• Publication Type: Conference Paper / Summary Text
• Volume: 130
• City: Georgia
• Country: United States Of America